Encephalitis

References

Key articles

Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis. 2013 Oct;57(8):1114-28.Full text  Abstract

Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Full text  Abstract

Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010 Aug;17(8):999-e57.Full text  Abstract

Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012 Apr;64(4):347-73.Full text  Abstract

Kneen R, Michael BD, Menson E, et al. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012 May;64(5):449-77.Full text  Abstract

Reference articles

1. Venkatesan A, Michael BD, Probasco JC, et al. Acute encephalitis in immunocompetent adults. Lancet. 2019 Feb 16;393(10172):702-16. Abstract

2. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis. 2013 Oct;57(8):1114-28.Full text  Abstract

3. Granerod J, Tam CC, Crowcroft NS, et al. Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010 Sep 7;75(10):924-32. Abstract

4. Boucher A, Herrmann JL, Morand P, et al. Epidemiology of infectious encephalitis causes in 2016. Med Mal Infect. 2017 May;47(3):221-35. Abstract

5. Vora NM, Holman RC, Mehal JM, et al. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology. 2014 Feb 4;82(5):443-51. Abstract

6. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PloS One. 2014 Sep 5;9(9):e104169.Full text  Abstract

7. Barbadoro P, Marigliano A, Ricciardi A, et al. Trend of hospital utilization for encephalitis. Epidemiol Infect. 2012 Apr;140(4):753-64. Abstract

8. Bernard S, Mailles A, Stahl JP, et al. Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data. Epidemiol Infect. 2013 Nov;141(11):2256-68. Abstract

9. Huppatz C, Durrheim DN, Levi C, et al. Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis. 2009 Sep;15(9):1359-65.Full text  Abstract

10. Kulkarni MA, Lecocq AC, Artsob H, et al. Epidemiology and aetiology of encephalitis in Canada, 1994-2008: a case for undiagnosed arboviral agents? Epidemiol Infect. 2013 Nov;141(11):2243-55. Abstract

11. Granerod J, Cousens S, Davies NW, et al. New estimates of incidence of encephalitis in England. Emerg Infect Dis. 2013;19(9).Full text  Abstract

12. Taba P, Schmutzhard E, Forsberg P, et al. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. Eur J Neurol. 2017 Oct;24(10):1214-e61. Abstract

13. UK Government guidance. Tick-borne encephalitis: epidemiology, diagnosis and prevention: Advice for health professionals on tick-borne encephalitis (TBE) including symptoms, diagnosis and epidemiology.Full text

14. European Centre for Disease Prevention and Control. Tick-borne encephalitis - annual epidemiological report for 2019. Mar 2021 [internet publication].Full text

15. Galanakis E, Tzoufi M, Katragkou A, et al. A prospective multicenter study of childhood encephalitis in Greece. Pediatr Infect Dis J. 2009 Aug;28(8):740-2. Abstract

16. Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis. 1998 Feb;26(2):398-409. Abstract

17. Lee TC, Guo HR, Su HJ, et al. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009 Oct;28(10):904-10. Abstract

18. Mailles A, Stahl JP; Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis. 2009 Dec 15;49(12):1838-47.Full text  Abstract

19. Srey VH, Sadones H, Ong S, et al. Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999-2000. Am J Trop Med Hyg. 2002 Feb;66(2):200-7. Abstract

20. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012 Apr;54(7):899-904.Full text  Abstract

21. Cho H, Proll SC, Szretter KJ, et al. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013 Apr;19(4):458-64.Full text  Abstract

22. Mekki M, Eley B, Hardie D, et al. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions. Dev Med Child Neurol. 2019 Oct;61(10):1139-44. Abstract

23. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med. 2005 Mar 17;352(11):1103-11.Full text  Abstract

24. Venkatesan A, Geocadin RG. Diagnosis and management of acute encephalitis: a practical approach. Neurol Clin Pract. 2014 Jun;4(3):206-15.Full text  Abstract

25. Britton PN, Eastwood K, Paterson B, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J. 2015 May;45(5):563-76.Full text  Abstract

26. Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):757-68.Full text  Abstract

27. World Health Organization. Tick-borne encephalitis: prevention. 2021 [internet publication].Full text

28. World Health Organization. Fact sheet - tick-borne encephalitis in Europe. 2021 [internet publication].Full text

29. US Centers for Disease Control and Prevention. Tick-borne encephalitis vaccine. Aug 2021 [internet publication].Full text

30. US Centers for Disease Control and Prevention. Tick-borne encephalitis. For healthcare providers. Vaccine. Mar 2022 [internet publication].Full text

31. Centers for Disease Control and Prevention. Japanese encephalitis vaccines. 25 July 2019 [internet publication].Full text

32. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009 Jan 15;360(3):244-56.Full text  Abstract

33. Koelman DLH, Brouwer MC, van de Beek D. Resurgence of pneumococcal meningitis in Europe and Northern America. Clin Microbiol Infect. 2020 Feb;26(2):199-204.Full text  Abstract

34. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011 May;69(5):892-900. Abstract

35. Gadoth A, Pittock SJ, Dubey D, et al. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017 Jul;82(1):79-92. Abstract

36. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013 Feb;12(2):157-65.Full text  Abstract

37. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404.Full text  Abstract

38. Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018 Mar 1;378(9):840-51.Full text  Abstract

39. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Full text  Abstract

40. van Sonderen A, Schreurs MW, Wirtz PW, et al. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time. Autoimmun Rev. 2016 Oct;15(10):970-4.Full text  Abstract

41. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014 Feb;13(2):167-77.Full text  Abstract

42. Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012 Dec;72(6):902-11.Full text  Abstract

43. Armangue T, Leypoldt F, Málaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014 Feb;75(2):317-23.Full text  Abstract

44. Armangue T, Moris G, Cantarín-Extremera V, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. 2015 Nov 17;85(20):1736-43.Full text  Abstract

45. Nosadini M, Mohammad SS, Corazza F, et al. Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol. 2017 Aug;59(8):796-805.Full text  Abstract

46. Gelfand JM, Genrich G, Green AJ, et al. Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge. JAMA Neurol. 2015 Jan;72(1):66-72. Abstract

47. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006 Aug 22;67(4):637-43. Abstract

48. Sano K, Satoh K, Atarashi R, et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One. 2013;8(1):e54915.Full text  Abstract

49. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006 Dec 15;43(12):1565-77.Full text  Abstract

50. Baumgartner A, Rauer S, Mader I, et al. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013 Nov;260(11):2744-53. Abstract

51. Lai CW, Gragasin ME. Electroencephalography in herpes simplex encephalitis. J Clin Neurophysiol. 1988 Jan;5(1):87-103. Abstract

52. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol. 2010 Oct;52(1):901-7. Abstract

53. Westmoreland BF. The EEG in cerebral inflammatory processes. In: Niedermeyer E, Lopes Da Silva F, eds. Electroencephalography. 4th ed. Baltimore, MD: Williams and Wilkins; 1999:302-16.

54. Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012 Sep 11;79(11):1094-100.Full text  Abstract

55. Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018 Jan;83(1):166-77.Full text  Abstract

56. Jakob NJ, Lenhard T, Schnitzler P, et al. Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med. 2012 Apr;40(4):1304-8. Abstract

57. Mook-Kanamori B, van de Beek D, Wijdicks EF. Herpes simplex encephalitis with normal initial cerebrospinal fluid examination. J Am Geriatr Soc. 2009 Aug;57(8):1514-5. Abstract

58. Weil AA, Glaser CA, Amad Z, et al. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. 2003 Apr 15;34(8):1154-7.Full text  Abstract

59. Fodor PA, Levin MJ, Weinberg A, et al. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology. 1998 Aug;51(2):554-9. Abstract

60. De Biasi RL, Tyler KL. Viral meningitis and encephalitis. Continuum: Lifelong Learn Neurol. 2006;12:36.

61. Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral encephalitis. Postgrad Med J. 2002 Oct;78(924):575-83.Full text  Abstract

62. Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014 Jun 19;370(25):2408-17.Full text  Abstract

63. Schraeder PL, Burns RA. Hemiplegic migraine associated with an aseptic meningeal reaction. Arch Neurol. 1980 Jun;37(6):377-9. Abstract

64. Feely MP, O'Hare J, Veale D, et al. Episodes of acute confusion or psychosis in familial hemiplegic migraine. Acta Neurol Scand. 1982 Apr;65(4):369-75. Abstract

65. Chakrapani A, Cleary MA, Wraith JE. Detection of inborn errors of metabolism in the newborn. Arch Dis Child Fetal Neonatal Ed. 2001 May;84(3):F205-10.Full text  Abstract

66. Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics. 1998 Dec;102(6):e69.Full text  Abstract

67. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84.Full text  Abstract

68. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010 Aug;17(8):999-e57.Full text  Abstract

69. Greenberg BM. Central nervous system infections in the intensive care unit. Semin Neurol. 2008 Nov;28(5):682-9. Abstract

70. Portegies P, Solod L, Cinque P, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol. 2004 May;11(5):297-304. Abstract

71. Makadzange AT, Mothobi N. Delaying initiation of ART for 5 weeks improves survival in patients with HIV infection with cyrptococcal meningitis. Evid Based Med. 2015 Feb;20(1):15. Abstract

72. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Cryptococcosis. 2021 [internet publication].Full text

73. Kumar R, Singhi S, Singhi P, et al. Randomized controlled trial comparing cerebral perfusion pressure-targeted therapy versus intracranial pressure-targeted therapy for raised intracranial pressure due to acute CNS infections in children. Crit Care Med. 2014 Aug;42(8):1775-87. Abstract

74. Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012 Apr;64(4):347-73.Full text  Abstract

75. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16;314(3):144-9. Abstract

76. Kneen R, Michael BD, Menson E, et al. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012 May;64(5):449-77.Full text  Abstract

77. Beckham JD, Tyler KL. Encephalitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010.

78. Yan HJ. Herpes simplex encephalitis: the role of surgical decompression. Surg Neurol. 2002 Jan;57(1):20-4. Abstract

79. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan;10(1):63-74.Full text  Abstract

80. McKeon A. Paraneoplastic and other autoimmune disorders of the central nervous system. Neurohospitalist. 2013 Apr;3(2):53-64.Full text  Abstract

81. Stingl C, Cardinale K, Van Mater H. An update on the treatment of pediatric autoimmune encephalitis. Curr Treatm Opt Rheumatol. 2018 Mar;4(1):14-28.Full text  Abstract

82. Nosadini M, Thomas T, Eyre M, et al. International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 22;8(5):e1052.Full text  Abstract

83. Bartolini L, Muscal E. Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey. J Neurol. 2017 Apr;264(4):647-53. Abstract

84. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008 Dec;7(12):1091-8.Full text  Abstract

85. Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special Issue. J Clin Apher. 2019 Jun;34(3):171-354. Abstract

86. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis: an update. Arch Neurol. 2005 Nov;62(11):1673-80.Full text  Abstract

87. Christie S, Chan V, Mollayeva T, et al. Systematic review of rehabilitation intervention outcomes of adult and paediatric patients with infectious encephalitis. BMJ Open. 2018 May 14;8(5):e015928.Full text  Abstract

88. Moorthi S, Schneider WN, Dombovy ML. Rehabilitation outcomes in encephalitis - a retrospective study 1990-1997. Brain Inj. 1999 Feb;13(2):139-46. Abstract

89. Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009 Aug;19(4):481-516. Abstract

90. Pöhlmann C, Schetelig J, Reuner U, et al. Cidofovir and foscarnet for treatment of Human Herpes Virus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis. 2007 Jun 15;44(12):e118-20.Full text  Abstract

91. Tunkel AR, Glaser CA, Bloch KC, et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. [Archived] Clin Infect Dis. 2008 Aug 1;47(3):303-27.Full text  Abstract

92. Pohl D, Tenembaum S. Treatment of acute disseminated encephalomyelitis. Curr Treat Options Neurol. 2012 Jun;14(3):264-75. Abstract

93. Meyer Sauteur PM, Jacobs BC, Spuesens EB, et al. Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis? PLoS Pathog. 2014 June 12;10(6):e1003983.Full text  Abstract

94. Iro MA, Martin NG, Absoud M, et al. Intravenous immunoglobulin for the treatment of childhood encephalitis. Cochrane Database Syst Rev. 2017 Oct 2;(10):CD011367.Full text  Abstract

95. Ben-Nathan D, Gershoni-Yahalom O, Samina I, et al. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis. 2009 Feb 17;9:18.Full text  Abstract

96. Wagner JN, Leibetseder A, Troescher A, et al. Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review. J Neurol. 2022 Feb;269(2):712-24.Full text  Abstract

97. Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2020-2021. Pediatrics. 2020 Oct;146(4):e2020024588.Full text  Abstract

98. Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology. 2015 Jan 27;84(4):359-66. Abstract

99. Thakur KT, Motta M, Asemota AO, et al. Predictors of outcome in acute encephalitis. Neurology. 2013 Aug 27;81(9):793-800.Full text  Abstract

100. Michaeli O, Kassis I, Shachor-Meyouhas Y, et al. Long-term motor and cognitive outcome of acute encephalitis. Pediatrics. 2014 Mar;133(3):e546-52. Abstract

101. McJunkin JE, Khan R, de los Reyes EC, et al. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics. 1997 Feb;99(2):261-7. Abstract

102. Fowler A, Stödberg T, Eriksson M, et al. Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol. 2008 Nov;12(6):484-90. Abstract

103. Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics. 2007 Feb;119(2):e399-407. Abstract

104. Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988 Sep;38(9):1407-10. Abstract

105. Singh TD, Fugate JE, Hocker SE, et al. Postencephalitic epilepsy: clinical characteristics and predictors. Epilepsia. 2015 Jan;56(1):133-8.Full text  Abstract

106. McGrath N, Anderson NE, Croxson MC, et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997 Sep;63(3):321-6.Full text  Abstract

107. Gabilondo I, Saiz A, Galán L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011 Sep 6;77(10):996-9. Abstract

108. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010 Jun;133(pt 6):1655-67.Full text  Abstract

109. Yeshokumar AK, Gordon-Lipkin E, Arenivas A, et al. Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunol. 2017 Nov 15;312:8-14. Abstract

110. Ariño H, Armangué T, Petit-Pedrol M, et al. Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome. Neurology. 2016 Aug 23;87(8):759-65.Full text  Abstract

111. van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology. 2016 Oct 4;87(14):1449-56. Abstract

112. Mailles A, De Broucker T, Costanzo P, et al; Steering Committee and Investigators Group. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis. 2012 May;54(10):1455-64.Full text  Abstract

113. Chou IC, Lin CC, Kao CH. Enterovirus encephalitis increases the risk of attention deficit hyperactivity disorder: a Taiwanese population-based case-control study. Medicine (Baltimore). 2015 Apr;94(16):e707. Abstract

114. Behan PO, Bakheit AM. Clinical spectrum of postviral fatigue syndrome. Br Med Bull. 1991 Oct;47(4):793-808. Abstract

115. Pradhan S, Pandey N, Shashank S, et al. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999 Nov 10;53(8):1781-6. Abstract

116. Muñoz-Lopetegi A, Graus F, Dalmau J, et al. Sleep disorders in autoimmune encephalitis. Lancet Neurol. 2020 Dec;19(12):1010-22. Abstract

117. Blattner MS, de Bruin GS, Bucelli RC, et al. Sleep disturbances are common in patients with autoimmune encephalitis. J Neurol. 2019 Apr;266(4):1007-15.Full text  Abstract

118. Anderson KN, Kelly TP, Griffiths TD. Primary sleep disorders can cause long-term sleep disturbance in patients with autoimmune mediated limbic encephalitis. Clin Neurol Neurosurg. 2013 Jul;115(7):1079-82.Full text  Abstract

119. Blattner MS, Day GS. Sleep disturbances in patients with autoimmune encephalitis. Curr Neurol Neurosci Rep. 2020 Jun 10;20(7):28.Full text  Abstract

120. Centers for Disease Control (CDC). West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009 Nov 20;58(45):1263-7.Full text  Abstract

121. Pisani G, Cristiano K, Pupella S, et al. West Nile virus in Europe and safety of blood transfusion. Transfus Med Hemother. 2016 May;43(3):158-67.Full text  Abstract

Use of this content is subject to our disclaimer